skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

23 Total results for product and free and sample content found

Pink Sheet

Drug Pricing Response: The 1,000-Day Report

By Michael McCaughan 30 May 2019

HHS’ “First 100 Days” take on the drug pricing “Blueprint” is a novel use of a tried-and-true milestone for presidential action. But it is probably more enlightening to look at what has happened in the 1,000 days since drug pricing became the overwhelming focus of political attention.

Topic us-election

Medtech Insight

Inspection Tips Experimentation And Trump

By David Filmore 04 Jan 2018

2017 was obviously dominated by news of political chaos coming out of the White House and, for the medtech industry

Topic us-election


Biotech Execs Speak Out Against Trump's Immigration Ban

By Brenda Sandburg 13 Feb 2017

Letter initiated by six CEOs drew 'absolutely overwhelming' response as 163 leaders of primarily small biotech and venture capital firms signed on; tech firms join court fight.

Topic Press release us-election

Medtech Insight

Public Citizen Challenges Trump's Regulation Executive Order

By Derrick Gingery 13 Feb 2017

A lawsuit claims that Trump overstepped presidential authority.

Topic us-election

Pink Sheet

Rogue FDA Tweeters Archive Inspection Data, Fearing Deletion By Trump

By Bowman Cox 02 Feb 2017

Followers of rogue FDA twitter site AltFDA answered a call to back up inspection citations data the Obama administration made public in case the Trump administration erases it from the FDA website.

Topic us-election


Big Pharma Subdued In Its Response To Trump's Travel EO

30 Jan 2017

Big pharma has been muted in its response to President Trump's executive order imposing severe travel restrictions on nationals from seven Muslim-majority countries for 90 days. Small biotech, however, has no reservations about speaking out against the so-called 'immigration ban'.

Topic us-election Policy and regulation


IDMA Meet: Trump, Protectionism, New Markets And Cricket

By Anju Ghangurde 23 Jan 2017

The Trump presidency and the threat of protectionism, new generic opportunities beyond the US market, and the need for new quality benchmarks were some of the key issues discussed at the recent annual day celebrations of the Indian Drug Manufacturers’ Association.

Topic Strategy us-election

Pink Sheet

Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’

By Derrick Gingery 19 Jan 2017

Incoming president not holding over any FDA political appointees from the Obama administration, but what exactly his stamp on the agency will be remains unclear.

Topic us-election FDA


The Bully Pulpit: Trump Versus Drug Prices

By Michael McCaughan 18 Jan 2017

Medicare price negotiation is not a new idea – nor is the concept of using the Presidential megaphone to talk down drug prices. Will Trump and Twitter turn it into something bigger?

Topic us-election

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: